1.
García X,
Martín J,
Maurel J,
Cubedo R,
Bague S,
de Alava E,
López A,
Narvaéz JA,
Ortiz E,
Pomes J,
Poveda A,
Pérez L,
Tenderom O,
y Viñals JM.
GuÍa de praáctica clínica en los sarcomas de partes blandas.
Med Clin (Barc).
2011;136(9):408.e1–408.e18.
2.
Bestic JM,
Peterson JJ,
Bancroft LW.
Use of FDG PET inStaging,
Restaging,and Assessment of Therapy Response in Ewing Sarcoma.
RadioGraphics 2009; 29:1487–1501.
3.
Warren H,
Kransdorf MJ,
Bancroft LW,
Peterson JJ,
Berquist TH,
Murphey MD.
Benign and Malignant Soft-Tissue Tumors: Posttreatment MR Imaging.
RadioGraphics 2009; 29:119–134
4.
Robinson E,
Bleakney RR,
Ferguson PC,
O´Sullivan B.
Oncodiagnosis Panel: 2007 Multidisciplinary Management of Soft- Tissue Sarcoma.RadioGraphics 2008; 28:2069–2086.
5.
M.
Vaquero M,
Piera J,
Ciria JP,
Oñatibia A,
González J.
Protocolo: diagnóstico y tratamiento de los sarcomas de partes blandas.
Hospital Donostia Ospitalea.
Osakidetza Servicio vasco de salud.
6.
Kuhlman JE,
Bouchardy L,
Fishman EK,
Zerhouni EA.
CT and MR Imaging Evaluation of Chest Wall Disorders.
RadioGraphics 1994; 14:571-595.
7.
Beaman FD,
Kransdorf MJ,
Andrews TR,
Murphey MD,
Arcara LK,
Keeling JH.
Superficial Soft-Tissue Masses: Analysis,
Diagnosis,
and Differential Considerations.
RadioGraphics 2007; 27:509–523